Just another WordPress site
When Does Integrity Die?Eli Lilly & Co. will pay a combined $1.42 billion, that’s “B” as in billion (1000 million) in fines and settlements for their actions in marketing Zyprexa off label for dementia. “Off Label” is term the FDA uses when a medicine is used for some other reason than stated in the literature of the product. The CEO of Eli Lilly, John C. Lechleiter, Ph.D. is not the...